During the past decade, Swedish Urology Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Swedish Urology Group" are "Kidney Cancer" (1 trials), "Prostate Cancer" (1 trials), "Renal Cell Carcinoma" (1 trials) and "Urinary Incontinence" (1 trials). Many other conditions were trialed in "Swedish Urology Group" in a lesser frequency.

Most popular intervention types in "Swedish Urology Group" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ceevra Reveal" (2 trials), "Placebo" (1 trials) and "solifenacin succinate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Swedish Urology Group" are 2 trials for "Male" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Swedish Urology Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Swedish Urology Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Swedish Urology Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".